Eruption of Metastatic Paraganglioma After Successful Therapy with (177)Lu/(90)Y-DOTATOC and (177)Lu-DOTATATE

ABSTRACT: Metastatic paraganglioma treatment options are limited. Peptide receptor radionuclide therapy (PRRT) has been introduced as a novel management option for metastatic neuroendocrine tumors demonstrating safety, efficacy, and increased quality of life. We present two cases of marked progressi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nucl Med Mol Imaging
Autors principals: Wolf, Katherine I., Jha, Abhishek, van Berkel, Anouk, Wild, Damian, Janssen, Ingo, Millo, Corina M., Janssen, M. J. R., Gonzales, Melissa K., Timmers, Henri J. K. M., Pacak, Karel
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2019
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554376/
https://ncbi.nlm.nih.gov/pubmed/31231443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-019-00579-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars